Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous combined estrogen/progestin hormone replacement therapy

W C Andrews1

  • 1Eastern Virginia Medical School, Norfolk, USA.

Clinical Therapeutics
|September 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An analysis of 416 consecutive cesarean sections.

American journal of obstetrics and gynecology·2010
Same author

HEDIS measure for the management of menopause.

The American journal of managed care·2001
Same author

Approaches to taking a sexual history.

Journal of women's health & gender-based medicine·2000
Same author

What's new in preventing and treating osteoporosis?

Postgraduate medicine·1998
Same author

The transitional years and beyond.

Obstetrics and gynecology·1995
Same author

Hormonal management of fibrocystic disease of the breast.

The Journal of reproductive medicine·1990
Same journal

Early Feasibility Studies in Europe: A Multisite Qualitative Study of Operational Challenges and Site Selection Determinants at 6 University Hospitals.

Clinical therapeutics·2026
Same journal

Safety of Celecoxib in Elderly Patients With Osteoarthritis: A Real-World Analysis Based on the FAERS Database.

Clinical therapeutics·2026
Same journal

Reimagining Representation Across the Clinical Research Ecosystem: Part II of a Specialty Update on Advancing Diversity, Racial Equity, and Inclusion in Clinical Research.

Clinical therapeutics·2026
Same journal

Combined Effects of Nicorandil and Enhanced External Counterpulsation on Coronary Microcirculation and Exercise Capacity in Patients With Coronary Slow Flow Phenomenon: A Randomized, Controlled, 3-Arm Trial.

Clinical therapeutics·2026
Same journal

Phase 1 Study Evaluating Gefurulimab Pharmacokinetics and Safety Following Delivery Via Autoinjector or Prefilled Syringe With Needle Safety Device in Healthy Adults.

Clinical therapeutics·2026
Same journal

Evaluating Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Newer Antiseizure Medications Using FAERS and JADER Combined With Bioinformatics Exploration.

Clinical therapeutics·2026
See all related articles

This study evaluates a continuous combined hormone replacement therapy regimen for menopause, finding it beneficial for cardiovascular health and bone density while reducing endometrial hyperplasia risks. Bleeding patterns change over time, and breast cancer risks require further large-scale investigation.

Area of Science:

  • Menopause Management
  • Hormone Replacement Therapy (HRT)
  • Gynecology

Background:

  • Menopausal women require information on HRT benefits and risks.
  • Various HRT regimens are available, each with unique profiles.

Purpose of the Study:

  • To assess the effects of a continuous combined regimen of conjugated equine estrogen and medroxyprogesterone acetate.
  • To evaluate its impact on cardiovascular risk factors, carbohydrate metabolism, coagulation, blood pressure, bone mineral density, and endometrial health.

Main Methods:

  • Analysis of a continuous combined regimen (conjugated equine estrogen 0.625 mg and medroxyprogesterone acetate 2.5 mg).
  • Comparison of effects against estrogen alone, cyclical regimens, and baseline.

Main Results:

Related Experiment Videos

  • Maintains cardiovascular benefits, with less pronounced HDL cholesterol impact than estrogen alone.
  • No significant changes in carbohydrate metabolism, coagulation, or blood pressure.
  • Increased bone mineral density more than cyclical regimens.
  • Substantially reduced endometrial hyperplasia compared to unopposed estrogen.
  • Lower irregular bleeding frequency than estrogen alone, with increasing amenorrhea over time.

Conclusions:

  • Continuous combined HRT offers benefits for cardiovascular risk factors and bone health.
  • It significantly reduces endometrial hyperplasia risk.
  • Further large-scale studies are needed to clarify breast cancer risks associated with continuous regimens.